Complete financial analysis of Chordate Medical Holding AB (publ) (CMH.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chordate Medical Holding AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- XTB S.A. (XTB.WA) Income Statement Analysis – Financial Results
- PT Cisarua Mountain Dairy Tbk (CMRY.JK) Income Statement Analysis – Financial Results
- Integritas Viager (MLVIE.PA) Income Statement Analysis – Financial Results
- Tonogold Resources, Inc. (TNGL) Income Statement Analysis – Financial Results
- Public joint-stock company Asko-Strakhovanie (ACKO.ME) Income Statement Analysis – Financial Results
Chordate Medical Holding AB (publ) (CMH.ST)
About Chordate Medical Holding AB (publ)
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 976.28K | 108.52K | 882.05K | 618.01K | 1.16M | 945.11K | 995.32K | 165.91K | 645.15K |
Cost of Revenue | 437.70K | 74.46K | -1.04M | -1.90M | -907.71K | 991.35K | 463.50K | -233.30K | 388.47K |
Gross Profit | 538.59K | 34.06K | 1.93M | 2.51M | 2.07M | -46.24K | 531.82K | 399.22K | 256.67K |
Gross Profit Ratio | 55.17% | 31.39% | 218.26% | 406.85% | 178.00% | -4.89% | 53.43% | 240.62% | 39.79% |
Research & Development | 1.22M | 1.22M | 304.06K | 1.20M | 3.60M | 3.60M | 3.60M | 0.00 | 0.00 |
General & Administrative | 0.00 | 19.83M | 16.46M | 13.69M | 17.89M | 14.66M | 10.57M | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.64M | 6.03M |
SG&A | 92.94K | 19.83M | 16.46M | 13.69M | 17.89M | 14.66M | 10.57M | 4.64M | 6.03M |
Other Expenses | 0.00 | 8.22M | 7.20M | 8.25M | 8.73M | 11.93M | 13.08M | 13.63M | 10.92M |
Operating Expenses | 1.31M | 28.06M | 23.67M | 21.93M | 26.61M | 26.59M | 23.65M | 18.28M | 16.96M |
Cost & Expenses | 30.61M | 28.13M | 22.62M | 20.04M | 25.71M | 27.58M | 24.12M | 18.04M | 17.35M |
Interest Income | 391.58K | 81.15K | 24.89K | 338.27K | 346.78K | 0.00 | 27.00 | 5.53K | 1.36M |
Interest Expense | 6.68K | 0.00 | 24.89K | 338.27K | 346.78K | 473.83K | 220.91K | 749.81K | 738.33K |
Depreciation & Amortization | 1.24M | 1.24M | 1.24M | 1.37M | 2.01M | 8.06M | 7.93M | 6.92M | 5.97M |
EBITDA | -27.94M | -26.79M | -20.50M | -18.05M | -22.54M | -18.15M | -15.20M | -9.05M | -9.48M |
EBITDA Ratio | -2,862.19% | -23,563.94% | -2,290.17% | -2,726.92% | -1,627.22% | -1,964.05% | -1,527.41% | -4,102.86% | -1,451.87% |
Operating Income | -29.57M | -28.02M | -21.74M | -19.42M | -24.54M | -26.62M | -23.13M | -15.96M | -16.70M |
Operating Income Ratio | -3,029.00% | -25,824.63% | -2,464.88% | -3,142.46% | -2,108.95% | -2,816.63% | -2,324.37% | -9,620.94% | -2,588.75% |
Total Other Income/Expenses | 384.90K | 81.15K | -24.89K | -338.27K | -346.78K | -473.83K | -233.90K | 2.25M | 623.44K |
Income Before Tax | -29.19M | -27.94M | -21.77M | -19.76M | -24.89M | -26.69M | -23.36M | -13.71M | -16.08M |
Income Before Tax Ratio | -2,989.58% | -25,749.85% | -2,467.70% | -3,197.19% | -2,138.75% | -2,823.52% | -2,346.57% | -8,262.10% | -2,492.12% |
Income Tax Expense | 0.00 | -81.15K | 24.89K | 338.27K | 346.78K | -408.63K | 220.91K | -428.00 | 63.90K |
Net Income | -29.19M | -27.94M | -21.77M | -19.76M | -24.89M | -26.69M | -23.36M | -13.71M | -16.14M |
Net Income Ratio | -2,989.58% | -25,749.85% | -2,467.70% | -3,197.19% | -2,138.75% | -2,823.52% | -2,346.57% | -8,261.84% | -2,502.02% |
EPS | -0.13 | -67.28 | -0.13 | -108.56 | -233.49 | -674.46 | -931.96 | -1.57K | -2.38K |
EPS Diluted | -0.13 | -67.28 | -0.13 | -108.56 | -233.49 | -674.46 | -931.96 | -1.57K | -2.38K |
Weighted Avg Shares Out | 224.51M | 415.32M | 171.97M | 182.02M | 106.60M | 39.57M | 25.06M | 8.73M | 6.78K |
Weighted Avg Shares Out (Dil) | 224.51M | 415.32M | 171.97M | 182.02M | 106.60M | 39.57M | 25.06M | 8.73M | 6.78K |
Source: https://incomestatements.info
Category: Stock Reports